Endless-backed educational resources supplier Findel has secured what is believed to be the UK education supplies sector’s first sustainability-linked loan facility from lender Santander UK.

Limak Investment and Actis, a global sustainable infrastructure investor, have completed a share transfer of Uluğ Energy Distribution and Retail Services Co (Uluğ). The Share Purchase Agreement, which was first signed in September 2021, has met the necessary requirements of the Turkish Competition Authority, the Republic of Turkey Energy Market Regulatory Authority and other necessary authorisations. As a result, 100 per cent of shares in Uluğ have been transferred from Limak Investments to Actis.   Uluğ provides electricity distribution and retail services to the South Marmara Region of Turkey, which includes the provinces of Bursa, Balıkesir, Çanakkale and Yalova.  

Swedish cybersecurity specialist Pointsharp, backed by Main Capital Partners (Main), has made its second add-on deal with the acquisition of German-based secure communication specialist Cryptshare AG. Pointsharp enables companies to build a better, modern and more secure workplace. Main first invested in Pointsharp in 2020 to support the company in its next phase of growth, with a keen focus on international expansion. In 2021, Swedish company Secmaker was added to the Pointsharp portfolio, which created a leading Nordic player in the Identity and Access Management market (IAM). This acquisition of Cryptshare further strengthens Pointsharp’s position as a leading security software

Invizius Limited (Invizius), a VC-backed biotechnology company developing treatments to suppress unwanted innate immune responses, has been awarded a GBP1 million grant to bring H-Guard, its proprietary priming solution, designed to reduce the life-threatening inflammatory effects of haemodialysis, to the clinic. The funds will be used towards H-Guard’s First-in-Man safety study commencing in 2022.   Invizius is supported by a strong syndicate of investors including Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures, Calculus Capital and experienced life science entrepreneur and investor, Dr Jonathan Milner. The Company has established the regulatory pathway for H-Guard in North America and

TransFICC, a specialist provider of low-latency connectivity and workflow services for Fixed Income and Derivatives Markets, has closed a USD17 million Series A extension led by AlbionVC. All existing institutional shareholders also took part in this investment round, which follows the original Series A of USD7.8 million, announced in April 2020. TransFICC’s investors are AlbionVC, Citi, HSBC, Illuminate Financial, ING Ventures, and Main Incubator (the Early Stage CVC unit of Commerzbank Group). The new investment will primarily be used to expand TransFICC’s Engineering teams, to support additional venue connectivity and automated workflows in US Rates and Credit markets, including US

KKR, backed by the International Finance Corporation IFC) and Pavilion Capital, has led a USD77.5 million Series C round in Gtowsari, a Philippines-based B2B e-commerce platform. This latest round, which saw KKR invest USD45 million, brings Growsari’s total funding to USD110 million. The company’s existing investors include Robinson Retail Holdings, JG Digital Equity Ventures, and Wavemaker Partners. The new funding will be used to finance the expansion of Growsari’s footprint in the Philippines.

Cloaked, a consumer-first privacy company that enables individuals to safely share personal data with people or companies based on their level of comfort, has secured USD25 million in Series A funding round. The round was co-led by Lux Capital and Human Capital. Founded by two brothers, Arjun and Abhijay Bhatnagar, Cloaked is changing the way people use their data and setting rules for how that information can be used – without changing every day behaviour.

FirstPort, a UK residential property services company, is being acquired by Emeria, a European specialist in residential real estate services, from the company’s previous majority shareholder, the mid-market private equity investor Equistone Partners Europe Limited (Equistone). FirstPort will operate as a subsidiary of Emeria, with its existing management team remaining in place and reinvesting in the group. The financial terms of the deal are undisclosed and completion of the transaction remains subject to approval by the Financial Conduct Authority.   FirstPort works with developers, investors, freeholders and over 1,300 Resident Management Companies (RMCs) to provide services to leaseholders.  Emeria is

Integra Therapeutics, a biotechnology company that creates next- generation gene writing tools, has closed an additional EUR1.5-million investment from venture capital firm Columbus Venture Partners. This investment comes on top of the EUR4.5 million Integra Therapeutics raised last December from AdBio Partners, Invivo Capital and Takeda Ventures and completes its seed round in line with the company’s set goals. The new funds will go to support development of the FiCAT platform prototype and preclinical validation with in vivo and ex vivo models. 

Charme Capital Partners (Charme), a pan-European mid-market private equity firm, and Amadeus Capital Partners (Amadeus), are to sell 100 per cent of Veritas Intercontinental to LetsGetChecked, a global healthcare solutions company. LetsGetChecked, which is based in Dublin and New-York, the tools to manage health from home through direct access to diagnostic testing, virtual care, and medication delivery for a wide range of health and wellness conditions.  Veritas Intercontinental was founded in 2018 as a spin-off from Veritas Genetics and has led the activity and development of the Veritas brand outside of the United States, offering a wide range of genomic